Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation

BACKGROUND: Triple negative breast cancer (TNBC) is a malignancy with very poor prognosis, due to its aggressive clinical characteristics and lack of response to receptor-targeted drug therapy. In TNBC, immune-related pathways are typically upregulated and may be associated with a better prognosis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Velloso, Fernando J., Campos, Alexandre R., Sogayar, Mari C., Correa, Ricardo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385390/
https://www.ncbi.nlm.nih.gov/pubmed/30791886
http://dx.doi.org/10.1186/s12864-019-5523-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385390/
https://www.ncbi.nlm.nih.gov/pubmed/30791886
http://dx.doi.org/10.1186/s12864-019-5523-6

Ejemplares similares